Himcure Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.45 M
- Revenue Growth -41.18%
- Profit Growth -433.72%
- Ebitda -93.64%
- Net Worth -789.85%
- Total Assets 0.46%
About Himcure Pharmaceuticals
Himcure Pharmaceuticals Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2012 and has a history of 12 years and three months. Its registered office is in Rampur, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.45 M.
Nadeema Begum and Shumaila serve as directors at the Company.
Company Details
-
Location
Rampur, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74120UP2012PTC053568
-
Company No.
053568
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Nov 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Himcure Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nadeema Begum
|
Director | 09-Nov-2012 | Current |
|
Shumaila
|
Director | 09-Nov-2012 | Current |
Financial Performance of Himcure Pharmaceuticals.
Himcure Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.18% decrease. The company also saw a substantial fall in profitability, with a 433.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 789.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Himcure Pharmaceuticals?
Unlock access to Himcure Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Himcure Herbal Private LimitedNadeema Begum and Shumaila are mutual person
Charges (Loans)
₹2.45 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2019 | Others | ₹1.25 M | Open |
| 15 Mar 2019 | Others | ₹1.20 M | Open |
How Many Employees Work at Himcure Pharmaceuticals?
Unlock and access historical data on people associated with Himcure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Himcure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Himcure Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
